GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers left behind by modern medicine
Disease control Recruiting nowThis French study is testing whether a combination of two immunotherapy drugs can help control five types of advanced rare cancers that have progressed after standard treatment. It will enroll 154 adults whose cancers have specific rare origins, such as certain mesotheliomas, thy…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Radioactive 'Tumor-Seeking' drug tested to boost cancer surgery success
Disease control Recruiting nowThis small, early-stage study is testing whether it is safe and practical to give a targeted radioactive treatment (called PRRT) both before and after surgery to remove certain slow-growing digestive tract tumors that have spread. The goal is to see if this combined approach help…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Breakthrough radiation therapy targets Hard-to-Treat cancers with pinpoint precision
Disease control Recruiting nowThis study is testing a new targeted radiation treatment for adults with advanced neuroendocrine tumors that cannot be surgically removed or have spread. The treatment uses a radioactive substance that seeks out and delivers powerful radiation directly to cancer cells while tryin…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New radiation drug trial offers hope for Tough-to-Treat gut cancers
Disease control Recruiting nowThis study is testing whether a new radioactive drug called RYZ101 works better than standard treatments for advanced neuroendocrine tumors of the gut and pancreas. It's for people whose tumors have grown despite previous radiation therapy. The trial will measure how long the dru…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Tracking a targeted cancer therapy: can we predict who benefits most?
Knowledge-focused Recruiting nowThis study aims to better understand how patients with advanced neuroendocrine tumors (NETs) respond to a treatment called Peptide Receptor Radionuclide Therapy (PRRT). Researchers will collect detailed information from about 50 patients receiving this standard treatment to learn…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Methodist Health System • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
AI and advanced scans aim to personalize cancer treatment
Knowledge-focused Recruiting nowThis study aims to find better ways to predict which patients with advanced neuroendocrine tumors will benefit from a targeted radiation therapy. Researchers will use a special combined PET-MRI scan and artificial intelligence (AI) to analyze images from 80 patients before, durin…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Could your diet affect your tumor? new study investigates
Knowledge-focused Recruiting nowThis study aims to understand the link between nutrition and outcomes for patients with slow-growing digestive tumors. Researchers will observe 100 adult patients to see how many are malnourished and if their nutritional status is connected to their prognosis. The goal is to gath…
Matched conditions: GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC